Generex Biotech (GNBT) Receives $800K in Initial Purchase Orders for Crave-NX Diet Spray
Generex Biotechnology Corporation (NASDAQ: GNBT) today announced that it has thus far received an aggregate of over $800,000 in initial purchase orders for the Company's proprietary Crave-NX 7-Day Diet Aid Spray. These initial orders come as part of the Company's agreement announced earlier this week with a major nationwide pharmacy chain to market the Company's Crave-NX 7-Day Diet Aid Spray throughout the pharmacy's nationwide network of over 7,000 stores.
Create E-mail AlertRelated Categories
Corporate NewsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
